TBVI is continuously working on the development of new vaccine candidates.
The current TB vaccine pipeline (last update October 2018), is as follows:
TB vaccine pipeline 2018 based on Tag report 2018 and with input from developers
TBVI provides technical support for product and clinical development to TB vaccine researchers and developers.
TBVI consortium vaccine candidates – (revised d.d. July 2018)
Please read more about the Preclinical TB Vaccine candidates
Please read more about the Clinical TB Vaccine candidates
TB Vaccine development pathway
The TB vaccine pipeline requires a global and comprehensive coordination of efforts with defined stages of development and criteria for progression of individual vaccine candidates. To address this, the TB Vaccine Development Pathway is a newly established tool that provides a structured development path and gating criteria for TB vaccine candidates. It also describes the different functions and capabilities required to advance a candidate TB vaccine to its next stage of development. For more information about the Pathway, please visit www.TBVacPathway.org
For more information, please contact Daniëlle Roordink.